Angiotensin-converting enzyme inhibitors and angioedema

Allergy, Asthma and Immunology Research

Volumn 2, Issue 3, 2010, Pages 195-198

  Sánchez Borges, Mario ^a,b   González Aveledo, Luis A ^a  

^a Centro Medico Docente La Trinidad   (Venezuela)

^b Clinica El Avila   (Venezuela)

Author keywords

Angioedema; Angiotensin converting enzyme inhibitors; Bradykinin; Captopril; Enalapril

Indexed keywords

ANTIHISTAMINIC AGENT; BETAMETHASONE; CAPTOPRIL; CETIRIZINE; CHLORPHENIRAMINE; CORTICOSTEROID; DEXAMETHASONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FEXOFENADINE; HYDROCORTISONE; LORATADINE; PERINDOPRIL; PREDNISONE;

ADULT; AGED; ANGIOMYOLIPOMA; ANGIONEUROTIC EDEMA; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE SEVERITY; FEMALE; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; LARYNX; MALE; MEDICAL RECORD REVIEW; OROPHARYNX; OUTPATIENT DEPARTMENT; RETROSPECTIVE STUDY; TONGUE; TRACHEOSTOMY; TREATMENT DURATION;

EID: 77954060133     PISSN: 20927355     EISSN: 20927363     Source Type: Journal    
DOI: 10.4168/aair.2010.2.3.195     Document Type: Article

References (21)

1. Cicardi M, Agostoni A. Hereditary angioedema. N Engl J Med 1996;334:1666-7.
2. Quincke H. Über akutes umschriebenes Hautödem. Monatsh Prakt Dermatol 1882;1:129-31.
3. Lombardi C, Crivellaro M, Dama A, Senna G, Gargioni S, Passalacqua G. Are physicians aware of the side effects of angiotensin-converting enzyme inhibitors?: a questionnaire survey in different medical categories. Chest 2005;128:976-9.
4. Howes LG, Tran D. Can angiotensin receptor antagonists be used safely in patients with previous ACE inhibitor-induced angioedema? Drug Saf 2002;25:73-6.
5. Miller DR, Oliveria SA, Berlowitz DR, Fincke BG, Stang P, Lillienfeld DE. Angioedema incidence in US veterans initiating angiotensin-converting enzyme inhibitors. Hypertension 2008;51:1624-30.
6. Sarkar P, Nicholson G, Hall G. Brief review: angiotensin converting enzyme inhibitors and angioedema: anesthetic implications. Can J Anaesth 2006;53:994-1003. (Pubitemid 44822786)
7. Slater EE, Merrill DD, Guess HA, Roylance PJ, Cooper WD, Inman WH, Ewan PW. Clinical profile of angioedema associated with angiotensin converting-enzyme inhibition. JAMA 1988;260:967-70.
8. Dean DE, Schultz DL, Powers RH. Asphyxia due to angiotensin converting enzyme (ACE) inhibitor mediated angioedema of the tongue during the treatment of hypertensive heart disease. J Forensic Sci 2001;46:1239-43.
9. Cupido C, Rayner B. Life-threatening angio-oedema and death associated with the ACE inhibitor enalapril. S Afr Med J 2007;97:244-5. (Pubitemid 46614298)
10. Mlynarek A, Hagr A, Kost K. Angiotensin-converting enzyme inhibitor-induced unilateral tongue angioedema. Otolaryngol Head Neck Surg 2003;129:593-5.
11. Byrd JB, Touzin K, Sile S, Gainer JV, Yu C, Nadeau J, Adam A, Brown NJ. Dipeptidyl peptidase IV in angiotensin-converting enzyme inhibitor associated angioedema. Hypertension 2008;51:141-7.
12. Duan QL, Nikpoor B, Dube MP, Molinaro G, Meijer IA, Dion P, Rochefort D, Saint-Onge J, Flury L, Brown NJ, Gainer JV, Rouleau JL, Agostoni A, Cugno M, Simon P, Clavel P, Potier J, Wehbe B, Benarbia S, Marc-Aurele J, Chanard J, Foroud T, Adam A, Rouleau GA. A variant in XPNPEP2 is associated with angioedema induced by angiotensin I-converting enzyme inhibitors. Am J Hum Genet 2005;77:617-26.
13. Oike Y, Ogata Y, Higashi D, Matsumura T, Numata Y. Fatal angioedema associated with enalapril. Intern Med 1993;32:308-10.
14. Kostis JB, Kim HJ, Rusnak J, Casale T, Kaplan A, Corren J, Levy E. Incidence and characteristics of angioedema associated with enalapril. Arch Intern Med 2005;165:1637-42.
15. Chin HL, Buchan DA. Severe angioedema after long-term use of an angiotensin-converting enzyme inhibitor. Ann Intern Med 1990;112:312-3.
16. Kampitak T. Recurrent severe angioedema associated with imidapril and diclofenac. Allergol Int 2008;57:441-3.
17. Kamata Y, Iwamoto M, Kamimura T, Kanashiki E, Yoshio T, Okazaki H, Morita T, Minota S. Repeated massive tongue swelling due to the combined use of estramustine phosphate and angiotensin-converting enzyme inhibitor. J Investig Allergol Clin Immunol 2006;16:388-90.
18. Morimoto T, Gandhi TK, Fiskio JM, Seger AC, So JW, Cook EF, Fukui T, Bates DW. An evaluation of risk factors for adverse drug events associated with angiotensin-converting enzyme inhibitors. J Eval Clin Pract 2004;10:499-509.
19. Abbosh J, Anderson JA, Levine AB, Kupin WL. Angiotensin converting enzyme inhibitor-induced angioedema more prevalent in transplant patients. Ann Allergy Asthma Immunol 1999;82:473-6. (Pubitemid 29242314)
20. Malde B, Regalado J, Greenberger PA. Investigation of angioedema associated with the use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. Ann Allergy Asthma Immunol 2007;98:57-63. (Pubitemid 46106159)
21. Weber MA, Messerli FH. Angiotensin-converting enzyme inhibitors and angioedema: estimating the risk. Hypertension 2008;51:1465-7.